CRISPR/Cas9遺伝子編集の光学制御について
James Hemphill1, Erin K Borchardt, Kalyn Brown1
1†Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.
Journal of the American Chemical Society
|April 24, 2015
まとめ
研究者らは,精密な遺伝子編集制御のための光活性化CRISPR/Cas9システムを開発した. この遺伝子組み換えツールは,遺伝子機能の光学的なアクティベーションとデアクティベーションを可能にし,ゲノムエンジニアリングと遺伝子治療のアプリケーションを前進させます.
科学分野:
- バイオテクノロジー バイオテクノロジー
- 分子生物学は分子生物学である.
- 遺伝学 遺伝学とは
背景:
- CRISPR/Cas9は,生物医学研究における強力なツールです.
- アプリケーションには,ゲノムエンジニアリングと遺伝子治療が含まれています.
- 正確なアプリケーションでは,CRISPR/Cas9の条件付き制御が望ましい.
研究 の 目的:
- 遺伝子でコードされた,光で活性化されたCRISPR/Cas9システムを設計する.
- 光を用いてCas9の活性に対する条件付きの制御を達成するために.
- 遺伝子機能の光学制御を実証する.
主な方法:
- カス9にカージドライシンアミノ酸のサイト固有の設置.
- 生命力のあるライシン残留物の特定.
- 光学的なアクティベーションとデアクティベーションの実験.
主要な成果:
- ライトで活性化されたCas9.9を成功裏に設計しました.
- Cas9機能に対する光学制御が実証されました.
- 外生性遺伝子と内生性遺伝子の活性化と無活性化が示されました.
結論:
- 光で活性化されたCRISPR/Cas9システムは,条件付き制御を提供します.
- このエンジニアリングされたシステムは,高度なゲノム工学と遺伝子治療の潜在能力を有しています.
- 光学制御は,精密な遺伝子調節のための新しい方法を提供します.
関連する概念動画
CRISPR/Cas9 Genome Editing
3.2K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
3.2K
CRISPR
60.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
60.2K
CRISPR
19.0K
19.0K
CRISPR and crRNAs
20.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
20.4K
Homologous Recombination
65.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
65.9K


